Jump to:

LiDCO Group Fundamentals

Company Name LIDCO Group Last Updated 23 May 2019
Industry Health Care Sector Medical Equipment
Shares in Issue (m) 244.17 Market Cap (£m) 12.58
PE Ratio -6.44 Div per Share (p) 0.00
Div Yield 0.00 Div Cover 0.00
EPS -0.80 EPS Growth (%) 6.98
PEG -0.92 DPS Growth (%) n/a
Debt Ratio 0.00 Debt Equity Ratio 0.00
Net Gearing 5.65 Gross Gearing 25.28
Asset Equity Ratio 1.34 Cash Equity Ratio 26.28
Quick Ratio 1.73 Current Ratio 2.58
Price To Book Value 1.93 ROCE -32.72

LiDCO Group Dividends

Type Ex-Date Pay Date Currency Net Dividend Year Total

LiDCO Group Company Financials

Assets (£m) 2019 2018 2017
Tangible Assets 1 1 1
Intangible Assets 2 2 2
Investments 0 0 0
Total Fixed Assets 3 3 3
Stocks 2 1 1
Debtors 2 3 3
Cash & Equivalents 2 3 5
Other Assets 0 0 0
Total Assets 9 11 12
Liabilities (£m) 2019 2018 2017
Creditors within 1 year 2 2 2
Creditors after 1 year 0 0 0
Other Liabilities 0 0 0
Total Liabilities 2 2 2
Net assets 7 8 10
Equity (£m) 2019 2018 2017
Called up share capital 1 1 1
Share Premium 30 30 30
Profit / Loss -2 -2 0
Other Equity 9 9 9
Preference & Minorities 0 0 0
Total Capital Employed 7 8 10
Ratios 2019 2018 2017
Debt Ratio 0.00 0.00 0.00
Debt-to-Equity 0.00 0.00 0.00
Net Gearing 5.65 -6.87 -27.75
Gross Gearing 25.28 22.97 13.40
Assets / Equity 1.34 1.30 1.16
Cash / Equity 26.28 38.73 47.51
EPS -0.80 -0.86 0.09
Cash Flow (£m) 2019 2018 2017
Cash from operating activities -1 -1 1
Cashflow before financing -2 -2 -1
Increase in Cash -2 -2 3
Income (£m) 2019 2018 2017
Turnover 7 8 8
Cost of sales 2 3 3
Gross Profit 5 5 6
Operating Profit -2 -2 0
Pre-Tax profit -2 -2 0
Profit / Loss for the year 1 1 1

LiDCO Group Company Background

Sector Medical Equipment
Activities LiDCO plc is a supplier of non-invasive and minimally invasive hemodynamic equipment to hospitals used to monitor the amount of blood flowing around the body and ensure that vital organs are adequately oxygenated. LiDCO's products facilitate the application of hemodynamic optimisation protocols for high risk patients in both critical care units and in the operating theatre. Increasingly clinical studies are showing that the optimisation of patients' hemodynamic status in high risk patients produces better outcomes and reduced hospital stay. LiDCO's computer-based technology, originally developed at St Thomas' Hospital in London, has been shown to significantly reduce morbidity and complications, length of stay and overall costs associated with major surgery.
Latest Interim Date 09 Oct 2018
Latest Fiscal Year End Date 26 Mar 2019

LiDCO Group Directors

Appointed Director Position
15 Jun 2015 Matthew Giovanni Sassone Chief Executive Officer
11 Mar 2019 Timothy Richard Hall Chief Financial Officer
06 Mar 2017 Peter William Grant Non-Executive Chairman
11 Aug 2016 Philip Michael Cooper Non-Executive Director

LiDCO Group Contact Details

Company Name LIDCO Group
Company Address 16 Orsman Road, London N1 5QJ.
Company Telephone +44 (0)20 7749 1500
Company Website http://www.lidco.com/

LiDCO Group Advisors

Auditor Name Grant Thornton UK LLP
Auditor Address Grant Thornton House, Melton Street, Euston Square, London NW1 2EP.
Auditor Website http://www.grant-thornton.co.uk/
Auditor Telephone +44 (0)20 7383 5100
Registrar Name Capita Registrars
Registrar Address The Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU.
Registrar Website http://www.capitaregistrars.com/
Registrar Telephone 0870 162 3100
Broker Name finnCap
Broker Address 60 New Broad Street
Broker Website http://www.finncap.com/
Broker Telephone +44 (0)207 220 0500
Adviser Name finnCap
Adviser Address 60 New Broad Street
Adviser Website http://www.finncap.com/
Adviser Telephone +44 (0)207 220 0500
Solicitor Name Herbert Smith LLP
Solicitor Address Exchange House, Primrose Street, London EC2A 2HS.
Solicitor Website http://www.herbertsmith.com/
Solicitor Telephone +44 (0)20 7374 8000
Stockbroker Name n/a
Stockbroker Address n/a
Stockbroker Website n/a
Stockbroker Telephone n/a